Propargylglycine Inhibits Hypotaurine/Taurine Synthesis and Elevates Cystathionine and Homocysteine Concentrations in Primary Mouse Hepatocytes

Total Page:16

File Type:pdf, Size:1020Kb

Propargylglycine Inhibits Hypotaurine/Taurine Synthesis and Elevates Cystathionine and Homocysteine Concentrations in Primary Mouse Hepatocytes CORE Metadata, citation and similar papers at core.ac.uk Provided by Springer - Publisher Connector Amino Acids (2015) 47:1215–1223 DOI 10.1007/s00726-015-1948-7 ORIGINAL ARTICLE Propargylglycine inhibits hypotaurine/taurine synthesis and elevates cystathionine and homocysteine concentrations in primary mouse hepatocytes Halina Jurkowska · Martha H. Stipanuk · Lawrence L. Hirschberger · Heather B. Roman Received: 29 December 2014 / Accepted: 18 February 2015 / Published online: 13 March 2015 © The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Our investigation showed that hepatocytes iso- methionine resulted in higher intracellular concentrations / lated from cysteine dioxygenase knockout mice (Cdo1− −) of homocysteine, which is a cosubstrate for cystathionine / had lower levels of hypotaurine and taurine than Cdo1+ + β-synthase (CBS). It seems that PPG increases CBS-medi- hepatocytes. Interestingly, hypotaurine accumulates in cul- ated desulfhydration by enhancing homocysteine levels in tured wild-type hepatocytes. DL-propargylglycine (PPG, hepatocytes. There were no overall effects of PPG or geno- inhibitor of cystathionine γ-lyase and H2S production) dra- type on intracellular or medium glutathione levels. matically decreased both taurine and hypotaurine levels in wild-type hepatocytes compared to untreated cells. Addi- Keywords Cysteine dioxygenase · Taurine · tion of 2 mM PPG resulted in the decrease of the intracel- Hypotaurine · Cystathionine · Homocysteine · Cysteine lular taurine levels: from 10.25 5.00 observed in control, desulfuration ± to 2.53 0.68 nmol/mg protein (24 h of culture) and from ± 17.06 9.40 to 2.43 0.26 nmol/mg protein (control vs. ± ± PPG; 48 h). Addition of PPG reduced also intracellular Introduction hypotaurine levels: from 7.46 3.55 to 0.31 0.12 nmol/ ± ± mg protein (control vs. PPG; 24 h) and from 4.54 3.20 In mammals, cysteine is catabolized by several nonoxida- ± to 0.42 0.11 nmol/mg protein (control vs. PPG; 48 h). tive cysteinesulfinate-independent desulfuration pathways ± The similar effects of PPG on hypotaurine and taurine lev- as well as by oxidative cysteinesulfinate-dependent path- els were observed in culture medium. PPG blocked hypo- ways or it may be used for protein and glutathione synthe- taurine/taurine synthesis in wild-type hepatocytes, suggest- sis (Fig. 1). Cysteine is catabolized by several desulfuration ing that it strongly inhibits cysteinesulfinate decarboxylase reactions that release sulfur in a reduced oxidation state, (pyridoxal 5′-phosphate-dependent enzyme) as well as generating sulfane sulfur or hydrogen sulfide (H2S), which cystathionine γ-lyase. In the presence of PPG, intracellu- can be further oxidized to sulfate. Cysteine desulfuration is lar and medium cystathionine levels for both wild-type and accomplished by alternate reactions catalyzed by cystathio- / Cdo1− − cells were increased. Addition of homocysteine or nine β-synthase (CBS), cystathionine γ-lyase (CTH), and 3-mercaptopyruvate sulfurtransferase (MPST) (Fig. 1). The oxidative pathway leads to production of taurine or sulfate Handling Editor: H. Jakubowski. (Stipanuk and Ueki 2011). Taurine (2-aminoethanesulfonic acid) is synthesized H. Jurkowska · M. H. Stipanuk · L. L. Hirschberger · endogenously from cysteine or via conversion from H. B. Roman Division of Nutritional Sciences, Cornell University, methionine, but also provided by diet, especially fish and Ithaca, NY 14853, USA seafood. The main pathway of taurine synthesis in mam- mals involves the oxidation of L-cysteine by the cysteine * H. Jurkowska ( ) dioxygenase (CDO) to produce cysteine sulfinic acid. Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7 St., 31‑034 Kraków, Poland This acid is decarboxylated to hypotaurine by the cysteine e-mail: [email protected] sulfinic acid decarboxylase, which is finally oxidized to 1 3 1216 H. Jurkowska et al. Fig. 1 The production of taurine and desulfhydration Methionine pathways of cysteine L-Homocysteine Serine Cystathionine β-synthase L-Cystathionine Cystathionine γ-lyase Protein L-Cysteine Glutathione Cysteine dioksygenase Cysteine aminotransferase Cystathionine Cystathionine γ-lyase 3-mercaptopyruvate Cysteinesulfinate β-synthase sulfurtransferase Aspartate Cysteinesulfinate aminotransferase H S decarboxylase 2 2- Hypotaurine S03 Sulfidequinone reductase Sulfidedioxygenase Hypotaurine Sulfite dehydrogenase oxidase Sulfur transferase 2- 2- 2- Taurine S04 S03 SS03 taurine by hypotaurine dehydrogenase. The conversion of restricted by the low availability of cysteinesulfinate as the cysteinesulfinate to hypotaurine/taurine is minimized substrate for cysteinesulfinate decarboxylase, and taurine by the active transaminative catabolism of cysteinesulfinate production is increased when cysteinesulfinate increases in to pyruvate and inorganic sulfur (Rosa et al. 2014; Stipanuk response to an increase in the hepatic cysteine concentra- 2004; Hayes and Sturman 1981). tion and the associated increase in cysteine dioxygenase Taurine is the most abundant (~millimolar concentra- activity (Stipanuk 2004). tion) free amino acid that is involved in many fundamental Homocysteine and taurine are both sulfur-containing biological functions (Imae et al. 2014; Hansen et al. 2006; amino acids sharing the same biosynthetic pathway. As an Miyazaki and Matsuzaki 2014). In liver, the most estab- end product of the transsulfuration pathway in homocyst- lished role of taurine is its conjugation with bile acids for eine metabolism, taurine supplementation may play a cru- excretion into bile (Danielsson 1963; Sjovall 1959). How- cial role in methionine metabolism in liver (Deminice et al. ever, taurine has many other physiological and pharmaco- 2014). logical roles in liver and other tissues, including stabiliza- In this study, determination of taurine and hypotaurine tion of cellular plasma membrane (Pasantes et al. 1985), levels in the primary cultures of hepatocytes partially con- 2 Ca + transport regulation (Huxtable 1992; Schaffer et al. firmed previous results from the experiments performed on 2010), osmoregulation (Nieminen et al. 1988; Huxtable mice (Roman et al. 2013; Ueki et al. 2011), and added new 1992; Schaffer et al. 2010), antioxidant effects (Huxtable insights to our understanding of metabolism of the studied / 1992; Nakamura et al. 1993; Schaffer et al. 2010; Rosa metabolites. Taurine level in Cdo1− − hepatocytes is low, / et al. 2014), anti-inflammation (Rosa et al. 2014), and as was observed previously in the liver of Cdo1− − mice. detoxification (Huxtable1992 ). Taurine supplementation Taurine levels in the cultured hepatocytes isolated from / has shown protective effects—such as antioxidant proper- Cdo1− − mice ranged from 4.6 to 6.2 % of the correspond- ties—to improve insulin sensitivity and dyslipidemia, as ing wild-type levels (this study), whereas taurine levels in / well as fatty liver disease, in rat models of obesity, diabe- the liver of Cdo1− − mice fed on taurine-free diets were tes type 2, and steatohepatitis (Deminice et al. 2014; Imae found to be consistently less than 5 % of the wild-type lev- et al. 2014; Balkan et al. 2002; Rosa et al. 2014; Xiao et al. els (previously published study). Hypotaurine level is neg- / / 2008). ligible in Cdo1− − hepatocytes as in the liver of Cdo1− − In liver, taurine is abundantly maintained by endogenous mice, reflecting the block in conversion of cysteine to biosynthesis and exogenous transport systems (Miyazaki cysteinesulfinate which is a precursor in the process of and Matsuzaki 2014). Hepatic taurine synthesis is largely hypotaurine/taurine synthesis. 1 3 Effect of propargylglycine on taurine synthesis and cystathionine and homocysteine levels in hepatocytes 1217 Interestingly, we have found in this study that signifi- Sigma–Aldrich). 2 mM DL-propargylglycine (PPG, Sigma– cant differences in hypotaurine and taurine levels in wild- Aldrich), 0.2 mM L-homocysteine (Hcy, Sigma–Aldrich), type hepatocytes compared to liver of wild-type mice were or 0.5 mM L-methionine (Met, Research Products Interna- shown. We have shown that hypotaurine accumulates in tional, Inc) was added as indicated. cultured wild-type hepatocytes. Hepatocytes were cultured in the treatment medium for In the present study, we have also investigated the effect 24 and 48 h prior to harvest. For measurement of metabo- of propargylglycine (PPG; inhibitor of gamma-cystathion- lite levels in the medium, the medium was removed prior ase) on hepatic hypotaurine and taurine synthesis and the to harvesting the hepatocytes and immediately frozen and levels of cystathionine, total unbound homocysteine, and stored at 80 °C for later analysis. For measurement of − glutathione in hepatocytes isolated from wild-type and metabolite levels in cells, hepatocytes were harvested by Cdo1 knockout male mice. Interestingly, inhibitory effects treating with 0.25 % trypsin (Gibco #25200), washing with of PPG on hypotaurine/taurine synthesis were found in ice-cold PBS to remove trypsin, suspending released hepat- wild-type hepatocytes. In addition, this study proved that ocytes in ice-cold PBS, and centrifuging the cell suspen- PPG, as well as homocysteine and methionine, increase sion at 1600 g for 10 min at 4 °C to obtain the pelleted × cystathionine and homocysteine levels in the cells and in cells, which were immediately frozen and stored at 80 °C − the conditional medium, which might result in an intensifi- for later analysis.
Recommended publications
  • University Microfilms International 300 N
    INFORMATION TO USERS This was produced from a copy of a document sent to us for microfilming. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help you understand markings or notations which may appear on this reproduction. 1. The sign or "target” for pages apparently lacking from the document photographed is "Missing Page(s)”. If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting through an image and duplicating adjacent pages to assure you of complete continuity. 2. When an image on the film is obliterated with a round black mark it is an indication that the film inspector noticed either blurred copy because of movement during exposure, or duplicate copy. Unless we meant to delete copyrighted materials that should not have been filmed, you will find a good image of the page in the adjacent frame. If copyrighted materials were deleted you will find a target note listing the pages in the adjacent frame. 3. When a map, drawing or chart, etc., is part of the material being photo­ graphed the photographer has followed a definite method in “sectioning” the material. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again—beginning below the first row and continuing on until complete.
    [Show full text]
  • Cysteine Dioxygenase 1 Is a Metabolic Liability for Non-Small Cell Lung Cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M
    bioRxiv preprint doi: https://doi.org/10.1101/459602; this version posted November 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer Authors: Yun Pyo Kang1, Laura Torrente1, Min Liu2, John M. Asara3,4, Christian C. Dibble5,6 and Gina M. DeNicola1,* Affiliations: 1 Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 2 Proteomics and Metabolomics Core Facility, Moffitt Cancer Center and Research Institute, Tampa, FL, USA 3 Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA 4 Department of Medicine, Harvard Medical School, Boston, MA, USA 5 Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA, USA 6 Department of Pathology, Harvard Medical School, Boston, MA, USA *Correspondence to: [email protected]. Keywords: KEAP1, NRF2, cysteine, CDO1, sulfite Summary NRF2 is emerging as a major regulator of cellular metabolism. However, most studies have been performed in cancer cells, where co-occurring mutations and tumor selective pressures complicate the influence of NRF2 on metabolism. Here we use genetically engineered, non-transformed primary cells to isolate the most immediate effects of NRF2 on cellular metabolism. We find that NRF2 promotes the accumulation of intracellular cysteine and engages the cysteine homeostatic control mechanism mediated by cysteine dioxygenase 1 (CDO1), which catalyzes the irreversible metabolism of cysteine to cysteine sulfinic acid (CSA). Notably, CDO1 is preferentially silenced by promoter methylation in non-small cell lung cancers (NSCLC) harboring mutations in KEAP1, the negative regulator of NRF2.
    [Show full text]
  • Oxidative Stress and Inflammation in Hepatic Diseases
    Review Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine Kívia Queiroz de Andrade 1, Fabiana Andréa Moura 1,2, John Marques dos Santos 3, Orlando Roberto Pimentel de Araújo 3, Juliana Célia de Farias Santos 2 and Marília Oliveira Fonseca Goulart 3,* Received: 10 October 2015; Accepted: 4 December 2015; Published: 18 December 2015 Academic Editor: Guido Haenen 1 Pós Graduação em Ciências da Saúde (PPGCS), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] (K.Q.A.); [email protected] (F.A.M.) 2 Faculdade de Nutrição/Universidade Federal de Alagoas (FANUT/UFAL), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] 3 Instituto de Química e Biotecnologia (IQB), Universidade Federal de Alagoas (UFAL), Campus A. C. Simões, Tabuleiro dos Martins, 57072-970 Maceió, AL, Brazil; [email protected] (J.M.S.); [email protected] (O.R.P.A.) * Correspondence: [email protected]; Tel.: +55-82-98818-0463 Abstract: Liver disease is highly prevalent in the world. Oxidative stress (OS) and inflammation are the most important pathogenetic events in liver diseases, regardless the different etiology and natural course. N-acetyl-L-cysteine (the active form) (NAC) is being studied in diseases characterized by increased OS or decreased glutathione (GSH) level. NAC acts mainly on the supply of cysteine for GSH synthesis. The objective of this review is to examine experimental and clinical studies that evaluate the antioxidant and anti-inflammatory roles of NAC in attenuating markers of inflammation and OS in hepatic damage.
    [Show full text]
  • 1 Abietic Acid R Abrasive Silica for Polishing DR Acenaphthene M (LC
    1 abietic acid R abrasive silica for polishing DR acenaphthene M (LC) acenaphthene quinone R acenaphthylene R acetal (see 1,1-diethoxyethane) acetaldehyde M (FC) acetaldehyde-d (CH3CDO) R acetaldehyde dimethyl acetal CH acetaldoxime R acetamide M (LC) acetamidinium chloride R acetamidoacrylic acid 2- NB acetamidobenzaldehyde p- R acetamidobenzenesulfonyl chloride 4- R acetamidodeoxythioglucopyranose triacetate 2- -2- -1- -β-D- 3,4,6- AB acetamidomethylthiazole 2- -4- PB acetanilide M (LC) acetazolamide R acetdimethylamide see dimethylacetamide, N,N- acethydrazide R acetic acid M (solv) acetic anhydride M (FC) acetmethylamide see methylacetamide, N- acetoacetamide R acetoacetanilide R acetoacetic acid, lithium salt R acetobromoglucose -α-D- NB acetohydroxamic acid R acetoin R acetol (hydroxyacetone) R acetonaphthalide (α)R acetone M (solv) acetone ,A.R. M (solv) acetone-d6 RM acetone cyanohydrin R acetonedicarboxylic acid ,dimethyl ester R acetonedicarboxylic acid -1,3- R acetone dimethyl acetal see dimethoxypropane 2,2- acetonitrile M (solv) acetonitrile-d3 RM acetonylacetone see hexanedione 2,5- acetonylbenzylhydroxycoumarin (3-(α- -4- R acetophenone M (LC) acetophenone oxime R acetophenone trimethylsilyl enol ether see phenyltrimethylsilyl... acetoxyacetone (oxopropyl acetate 2-) R acetoxybenzoic acid 4- DS acetoxynaphthoic acid 6- -2- R 2 acetylacetaldehyde dimethylacetal R acetylacetone (pentanedione -2,4-) M (C) acetylbenzonitrile p- R acetylbiphenyl 4- see phenylacetophenone, p- acetyl bromide M (FC) acetylbromothiophene 2- -5-
    [Show full text]
  • Separation and Quantitation of Water Soluble Cellular Metabolites by Hydrophilic Interaction Chromatography-Tandem Mass Spectrometry Sunil U
    Journal of Chromatography A, 1125 (2006) 76–88 Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry Sunil U. Bajad a, Wenyun Lu a, Elizabeth H. Kimball a, Jie Yuan a, Celeste Peterson b, Joshua D. Rabinowitz a,∗ a Lewis-Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University, Princeton, NJ 08544, USA b Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA Received 13 January 2006; received in revised form 8 May 2006; accepted 10 May 2006 Available online 6 June 2006 Abstract A key unmet need in metabolomics is the ability to efficiently quantify a large number of known cellular metabolites. Here we present a liquid chromatography (LC)–electrospray ionization tandem mass spectrometry (ESI-MS/MS) method for reliable measurement of 141 metabolites, including components of central carbon, amino acid, and nucleotide metabolism. The selected LC approach, hydrophilic interaction chromatography with an amino column, effectively separates highly water soluble metabolites that fail to retain using standard reversed-phase chromatography. MS/MS detection is achieved by scanning through numerous selected reaction monitoring events on a triple quadrupole instrument. When applied to extracts of Escherichia coli grown in [12C]- versus [13C]glucose, the method reveals appropriate 12C- and 13C-peaks for 79 different metabolites. © 2006 Elsevier B.V. All rights reserved. Keywords: LC–ESI-MS/MS; Escherichia coli; Metabolomics; Metabonomics; Hydrophilic interaction chromatography; Bacteria; Metabolite; metabolism; Triple quadrupole; Mass spectrometry 1. Introduction pounds, likely capture most key metabolic end products and intermediates [5–8]. Thus, a key current need is an assay that The ability to quantify numerous mRNA in parallel using can reliably and efficiently measure these known compounds DNA microarrays has revolutionized biological science, with [9].
    [Show full text]
  • Identification of a Distinct Metabolomic Subtype of Sporadic ALS Patients
    bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of a Distinct Metabolomic Subtype of Sporadic ALS Patients Running title – Increased cysteine and glucose metabolism in sALS cases Qiuying Chen, PhD1*, Davinder Sandhu, M.S.1*, Csaba Konrad, PhD2, Dipa Roychoudhury, PhD3, Benjamin I. Schwartz1, Roger R. Cheng1, Kirsten Bredvik2, Hibiki Kawamata, PhD2, Elizabeth L. Calder, PhD4, Lorenz Studer, MD4, Steven. M. Fischer3, Giovanni Manfredi MD/PhD2* and Steven. S. Gross, PhD1* *Joint first/senior authors 1Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA 2Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA 3Agilent Technology, Santa Clara, CA, USA 4The Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Center, New York, NY. Keywords: sporadic amyotrophic lateral sclerosis, metabolomics, stable isotope tracing, trans-sulfuration, hypermetabolism, disease stratification, energy metabolism Co-Corresponding Authors: Steven S. Gross, PhD Department of Pharmacology Weill Cornell Medicine Phone: 212-746-6257 Email: [email protected] Giovanni Manfredi, MD/PhD Brain and Mind Research Institute Weill Cornell Medicine Phone: 646-962-8172 Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Number of characters: Title --- 94 Running head---48 Number of words: Title --- 13 Running head --- 8 Abstract---232 Introduction --- 549 Discussion --- 1126 Body of manuscript --- 5706 Number of figures: 8 Number of color figures: 8 Number of tables:1 2 bioRxiv preprint doi: https://doi.org/10.1101/416396; this version posted September 13, 2018.
    [Show full text]
  • Supplemental Table 1. Differences in Fasting Metabolites (All) by CKD Status in Plasma
    Supplemental table 1. Differences in fasting metabolites (all) by CKD status in plasma. Metabolites in bold show hits controlling FDR at 10%, in a model that controls for age, sex, race (white versus not), and weight. Ordered by subclasses of metabolites followed by adjusted percent difference between CKD and controls and adjusted p-value for difference. Metabolite % Difference p-value q-value Pathway in CKD, compared with controls Cystine (241.1 / 120.0) 33 2.60E-09 1.52E-08 Amino Acid Proline (116.1 / 70.0) 20 0.000195 0.000692 Amino Acid 2-Hydroxyisovaleric Acid (117.0 / 71.0) 47 0.000331 0.001139 Amino Acid Tyrosine (182.1 / 136.0) -13 0.000633 0.002014 Amino Acid Serine (106.0 / 60.0) -8 0.029507 0.065132 Amino Acid Glycine (76.0 / 30.1) 13 0.032003 0.06842 Amino Acid Leucine (132.1 / 86.0) -5 0.067499 0.139499 Amino Acid 5-Aminovaleric Acid (118.0 / 55.0) -4 0.127339 0.253324 Amino Acid Threonine (120.1 / 74.0 (2)) -7 0.145125 0.281179 Amino Acid Glutamine (147.1 / 84.0) 3 0.169291 0.318061 Amino Acid Valine (118.1 / 72.0) -4 0.201091 0.36138 Amino Acid Arginine (175.1 / 70.0) 5 0.209045 0.362752 Amino Acid Sarcosine (89.9 / 44.0) -7 0.209395 0.362752 Amino Acid Cadaverine (103.0 / 86.0) 4 0.281896 0.459935 Amino Acid Histidine (156.1 / 110.0) 3 0.319987 0.495386 Amino Acid Alanine (90.0 / 44.0) 5 0.330111 0.499193 Amino Acid iso-Leucine (132.1 / 86.0 (2)) -3 0.336431 0.50262 Amino Acid Phenylalanine (166.1 / 120.0) 2 0.461445 0.61526 Amino Acid Methionine (150.1 / 61.0) -3 0.516557 0.681415 Amino Acid Pipecolate (130.0 / 84.0) -2
    [Show full text]
  • Taurine Supplementation Improves the Utilization of Sulfur
    Available online at www.sciencedirect.com Journal of Nutritional Biochemistry 20 (2009) 132–139 Taurine supplementation improves the utilization of sulfur-containing amino acids in rats continually administrated alcohol Hui-Ting Yanga, Yi-Wen Chienb, Jen-Horng Tsenc, Ching-Chien Changb,d, ⁎ ⁎ Jer-Hwa Change, ,1, Shih-Yi Huangb, ,1 aSchool of Pharmaceutical Science, Taipei Medical University, Taipei bSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei cSchool of Nutrition, China Medical University, Taichung, Taiwan dGeneral Education Center, Northern Taiwan Institute of Science and Technology, Taipei eDepartment of Internal Medicine, Taipei Medical University Wan Fang Hospital, Taipei, Taiwan Received 27 September 2007; received in revised form 18 December 2007; accepted 4 January 2008 Abstract The main purpose of this study was to evaluate changes in brain sulfur-containing amino acid (SCAA) metabolism to determine whether taurine intervened under continuous alcohol intake. We fed 80 male Sprague–Dawley rats 30% alcohol-containing water for 4 weeks. Eighty animals were divided into two groups (with or without 2 g/kg body weight taurine supplementation), and five were killed every week in each group for monitoring SCAA changes in the brain, liver, kidneys and heart. Results indicated that the plasma alcohol concentration increased from Weeks 1–4; however, animals with taurine supplementation showed a lower plasma concentration of ethanol in Week 2. As to SCAA concentrations, cysteine and taurine were both lower after a week of alcohol ingestion in the brain and plasma; the same declining trend was shown in the liver in Week 2. In contrast, plasma and hepatic concentrations of homocysteine were elevated in Week 2, and the plasma S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio also decreased in Week 1.
    [Show full text]
  • S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure
    nutrients Article S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure Anna Maria Czarnecka , Wojciech Hilgier and Magdalena Zieli ´nska* Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawi´nskiego Street, 02-106 Warsaw, Poland; [email protected] (A.M.C.); [email protected] (W.H.) * Correspondence: [email protected]; Tel.: +48-22-6086470; Fax: +48-22-6086442 Received: 11 June 2020; Accepted: 15 July 2020; Published: 17 July 2020 Abstract: Background: Acute liver failure (ALF) impairs cerebral function and induces hepatic encephalopathy (HE) due to the accumulation of neurotoxic and neuroactive substances in the brain. Cerebral oxidative stress (OS), under control of the glutathione-based defense system, contributes to the HE pathogenesis. Glutathione synthesis is regulated by cysteine synthesized from homocysteine via the transsulfuration pathway present in the brain. The transsulfuration-transmethylation interdependence is controlled by a methyl group donor, S-adenosylmethionine (AdoMet) conversion to S-adenosylhomocysteine (AdoHcy), whose removal by subsequent hydrolysis to homocysteine counteract AdoHcy accumulation-induced OS and excitotoxicity. Methods: Rats received three consecutive intraperitoneal injections of thioacetamide (TAA) at 24 h intervals. We measured AdoMet and AdoHcy concentrations by HPLC-FD, glutathione (GSH/GSSG) ratio (Quantification kit). Results: AdoMet/AdoHcy ratio was reduced in the brain but not in the liver. The total glutathione level and GSH/GSSG ratio, decreased in TAA rats, were restored by AdoMet treatment. Conclusion: Data indicate that disturbance of redox homeostasis caused by AdoHcy in the TAA rat brain may represent a deleterious mechanism of brain damage in HE.
    [Show full text]
  • Combined Metabolic Activators Improve Cognitive Functions Without Altering Motor
    medRxiv preprint doi: https://doi.org/10.1101/2021.07.28.21261293; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson’s Disease Burak Yulug1,#, Ozlem Altay2,#, Xiangyu Li2, #, Lutfu Hanoglu3, Seyda Cankaya1, Simon Lam4, Hong Yang2, Ebru Coskun3, Ezgi İdil1, Rahim Nogaylar1, Ahmet Hacımuftuoglu5, Muhammad Arif2, Saeed Shoaie2,4, Cheng Zhang2.6, Jens Nielsen7, Hasan Turkez8, Jan Borén9, Mathias Uhlén2,*, Adil Mardinoglu2,4,* 1Department of Neurology and Neuroscience, Faculty of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey 2Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden 3Department of Neurology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey 4Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom 5Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey. 6School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, PR China 7Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden 8Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey 9Department
    [Show full text]
  • Mechanistic Study of Cysteine Dioxygenase, a Non-Heme
    MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE, A NON-HEME MONONUCLEAR IRON ENZYME by WEI LI Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Student Name Wei Li All Rights Reserved Acknowledgements I would like to thank Dr. Pierce for your mentoring, guidance and patience over the five years. I cannot go all the way through this without your help. Your intelligence and determination has been and will always be an example for me. I would like to thank my committee members Dr. Dias, Dr. Heo and Dr. Jonhson- Winters for the directions and invaluable advice. I also would like to thank all my lab mates, Josh, Bishnu ,Andra, Priyanka, Eleanor, you all helped me so I could finish my projects. I would like to thank the Department of Chemistry and Biochemistry for the help with my academic and career. At Last, I would like to thank my lovely wife and beautiful daughter who made my life meaningful and full of joy. July 11, 2014 iii Abstract MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE A NON-HEME MONONUCLEAR IRON ENZYME Wei Li, PhD The University of Texas at Arlington, 2014 Supervising Professor: Brad Pierce Cysteine dioxygenase (CDO) is an non-heme mononuclear iron enzymes that catalyzes the O2-dependent oxidation of L-cysteine (Cys) to produce cysteine sulfinic acid (CSA). CDO controls cysteine levels in cells and is a potential drug target for some diseases such as Parkinson’s and Alzhermer’s.
    [Show full text]
  • The Biosynthesis Reaction of Hypotaurine to Taurine
    UNIVERSITY OF CENTRAL OKLAHOMA Edmond, Oklahoma Jackson College of Graduate Studies The Biosynthesis Reaction of Hypotaurine to Taurine A THESIS SUBMITTED TO THE GRADUATE FACULTY In partial fulfillment of the requirements For the degree of MASTER OF SCIENCE IN BIOLOGY By Roxanna Q. Grove Edmond, Oklahoma 2018 Acknowledgments Working on this project has been a period of intense learning for me, not only in the scientific arena, but also on a personal level. Writing this thesis has had a significant impact on me. I would like to reflect on people who have been supported and helped me so much throughout this period. First of all, I would like to express my gratitude toward my advisor, Dr. Steven J. Karpowicz, for his devotion, inspiration, and guidance. I am so grateful to have the opportunity to work with such an intelligent, dedicated, and patient professor. I appreciate his vast knowledge and skills in many areas such as biochemistry, genetics, and bioinformatics, and his assistance in writing this thesis. I would like to thank the other members of my committee, Dr. Nikki Seagraves, Dr. Hari Kotturi, and Dr. Lilian Chooback, for their guidance, support, and for providing materials throughout this project. An exceptional thanks go to Dr. John Bowen of the Department of Chemistry for advice in the analytical laboratory and Dr. Susan L. Nimmo from the Department of Chemistry and Biochemistry at the University of Oklahoma for assistance with NMR. This project was supported by funding from the College of Mathematics and Science and a Research, Creative, and Scholarly Activities (RCSA) grant from the Office of High Impact Practices at UCO.
    [Show full text]